---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-005210"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:29:36.117507+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio sees 48% Q2 revenue growth YoY, H1 revenue tops $2M

## Summary
- Fiscal Q2 2026 revenue expected up ~48% YoY; readers more than double (+104% YoY).
- H1 2026 total revenue ~$2.01M (+36% YoY); cartridge sales +38%, readers +50%.
- CEO cites expanding installed base as foundation for recurring cartridge revenue.
- Company expects to file 10-Q for Q2 ended Dec 31, 2025 during week of Feb 9, 2026.

## SEC filing metadata
- accession: 0001493152-26-005210
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315226005210/0001493152-26-005210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315226005210/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-005210
- JSON: https://secwatch.observer/filing/0001493152-26-005210.json
- Plain text: https://secwatch.observer/filing/0001493152-26-005210.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.